In the MC38 mouse model, Gln (TrT) increased CD8+ T-cell infiltration in the TME and promoted infiltrating cells to secrete IFN-γ at tumor sites, draining lymph nodes, and spleen; mice treated with this SMI showed significant tumor growth inhibition. Here, CD8A is linked to neoplasm.